Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-4.17%
↓ 164% below average
Average (3y)
-1.58%
Historical baseline
Range
High:-0.06%
Low:-4.17%
CAGR
+316.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -4.17% | -123.7% |
| 2023 | -1.86% | -723.6% |
| 2022 | -0.23% | -292.5% |
| 2021 | -0.06% | - |